Saturday 17 October 2026
Export MDT’s income statement to Excel — free account
Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
94.75
0.70
−0.73%
Follow MDT
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 7 | 7 | 8 |
+8 more TTM periods Free account |
| 10.57% | 9.77% | 9.34% | 9.77% | ||
| 5.68% | 5.20% | 5.08% | 5.25% | ||
ROIC |
6.04% | 5.87% | 5.47% | 5.58% | |
Return on Tangible Assets |
26.07% | 23.37% | 21.20% | 22.45% | |
Average Days of Receivables |
61.81 | 66.68 | 65.41 | 67.09 | |
Free Cash Flow per Share |
4.79 | 4.23 | 4.22 | 4.06 | |
Free Cash Flow |
6,132.00 | 5,426.00 | 5,410.00 | 5,206.00 | |
Capital Expenditures |
(1,903.00) | (1,904.00) | (1,875.00) | (1,907.00) | |
| Other line items | |||||
Cash ROIC |
6.98% | 6.22% | 6.32% | 6.03% | |
Accounts Receivable Turnover |
5.95 | 5.53 | 5.69 | 5.50 | |
Accounts Payable Turnover |
5.00 | 5.00 | 5.14 | 4.84 | |
Inventory Turnover |
2.17 | 2.23 | 2.09 | 2.06 | |
Average Days of Payables |
74.88 | 75.86 | 75.20 | 78.59 | |
Days of Inventory on Hand |
172.69 | 170.75 | 184.68 | 187.45 | |
Tax Rate |
(0.20) | (0.21) | (0.17) | (0.16) | |
Research and Development Expense of Revenue |
7.77% | 7.90% | 8.13% | 8.17% | |
Selling, General and Administrative Expense of Revenue |
32.43% | 32.41% | 32.26% | 32.25% | |
Share Based Compensation of Revenue |
1.32% | 1.26% | 1.27% | 1.31% | |
Interest Coverage |
9.36 | 9.04 | 8.47 | 8.75 | |
Operating CF/Net income |
1.54 | 1.53 | 1.58 | 1.49 | |
Depreciation/Fixed assets |
0.39 | 0.40 | 0.43 | 0.42 | |
Capex/Depreciation |
(0.65) | (0.64) | (0.61) | (0.63) | |
Revenue per Share |
29.33 | 28.37 | 27.66 | 27.11 | |
Operating CF per Share |
6.28 | 5.72 | 5.68 | 5.55 | |
Capex per Share |
(1.49) | (1.49) | (1.46) | (1.49) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates